Thank you FDA for all you do for patients. As we hope to advance therapies for #Epilepsy including #DevelopmentalandEpilepticencephalopathy #DravetSyndrome #InfantileSpasms and other rare epilepsies, we rely on the FDA to continue to do their job of ensuring new therapies are safe and effective for patients in need!
What does FDA’s scientific expertise and regulatory transparency mean to you and your family? Thank you Shehnaaz Suliman, M.D. (MB ChB), M.B.A., M.Phil., Gunnar Esiason, and Peter Kolchinsky for sharing how the FDA works hard with industry and innovators to ensure new, safe, and effective medicines reach U.S. patients. While there is room for improvement and greater efficiency at the FDA, there is a lot to be proud of. Thanks for all the work they do to keep the American public safe and healthy. We look to them as partners in the ongoing effort to help the U.S. expand its global leadership in biomedical innovation. Watch the video and sign the support letter here:?https://lnkd.in/gDa695rB